Acorda to buy Civitas Therapeutics for $525 million

September 24, 2014 1:01 PM

4 0

The deal effectively ends Civitas’s plans to go public

Acorda Therapeutics Inc. said Wednesday that it has agreed to buy fellow neurological drug maker Civitas Therapeutics for $525 million in cash, effectively putting an end to Civitas’s plans to go public.

Also read: Spain plans $528M in environmental taxes to meet EU goals

Read more

To category page

Loading...